AstraZeneca Wins Victory In Prilosec Patent Battle

Law360, New York (August 20, 2008, 12:00 AM EDT) -- The U.S. Court of Appeals for the Federal Circuit handed a victory to AstraZeneca AB Wednesday, upholding a lower court ruling that generic-drug makers Apotex Corp. and Impax Laboratories Inc. infringed patents for the heartburn medication Prilosec.

The appeals court affirmed the U.S. District Court for the Southern District of New York's May 2007 order finding that Apotex and Impax infringed U.S. Patent Numbers 4,786,505 and 4,853,230, which relate to omeprazole, the active ingredient in Prilosec.

Apotex and Impax had challenged the district court's judgement of...
To view the full article, register now.